UNRESECTABLE
Clinical trials for UNRESECTABLE explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE trials appear
Sign up with your email to follow new studies for UNRESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New lung cancer combo aims to boost treatment success
Disease control Recruiting nowThis study tests a new way to give radiation therapy for stage III lung cancer that cannot be removed by surgery. It combines a smaller, faster radiation field with standard chemo and a follow-up immunotherapy drug called durvalumab. About 110 adults will be randomly assigned to …
Matched conditions: UNRESECTABLE
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
New radioactive implant takes aim at inoperable pancreatic cancer
Disease control Recruiting nowThis early study tests a new treatment called YntraDose™ for people with pancreatic cancer that cannot be removed by surgery. The treatment involves a one-time injection of a radioactive implant directly into the tumor, given alongside standard chemotherapy. The main goals are to…
Matched conditions: UNRESECTABLE
Phase: NA • Sponsor: BetaGlue Therapeutics SpA • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
New daily pill trial aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, REC-1245, in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or control the disease. About 170 participants will take …
Matched conditions: UNRESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC